Daniel K. Nomura
Fondateur chez Frontier Medicines Corp.
Postes actifs de Daniel K. Nomura
Sociétés | Poste | Début | Fin |
---|---|---|---|
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Fondateur | 01/01/2018 | - |
Corporate Officer/Principal | 01/01/2018 | - | |
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Private Equity Investor | 01/08/2023 | - |
Vicinitas Therapeutics
Vicinitas Therapeutics BiotechnologyHealth Technology Vicinitas Therapeutics is located in the US. Vicinitas Therapeutics is an American US-based biotechnology company that specializes in developing next-generation disease therapies using targeted protein stabilizers called Deubiquituinase Targeting Chimeras (DUBtacs). The company's mission is to solve critical problems in human health by developing disease therapies against an entire class of previously inaccessible disease-causing proteins. | Directeur/Membre du Conseil | 01/01/2022 | - |
Fondateur | 01/01/2022 | - | |
AH Capital Management LLC
AH Capital Management LLC Investment ManagersFinance AH Capital Management LLC (AH Capital Management) is a venture capital firm founded in 2009 by Marc Lowell Andreessen and Ben A. Horowitz. The firm is headquartered in Menlo Park, California. | Consultant / Advisor | 01/03/2023 | - |
Private Equity Investor | 01/03/2023 | - | |
Droia Ventures | Consultant / Advisor | 01/11/2022 | - |
Photys Therapeutics, Inc.
Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Consultant / Advisor | - | - |
Apertor Pharmaceuticals, Inc.
Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Alameda, CA. | Consultant / Advisor | - | - |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky. | Consultant / Advisor | - | - |
Mark Foundation
Mark Foundation Miscellaneous Commercial ServicesCommercial Services The Mark Foundation for Cancer Research is a charitable organization that partners with scientists worldwide to accelerate research for the prevention, diagnosis, and treatment of cancer. The Mark Foundation is based in New York, NY and was founded by Alexander Mark Knaster. The foundation has awarded over $200 million in grants to more than 100 academic institutions across 13 countries since 2017. The non-profit company's research programs focus on early career support, team science collaboration, new technology innovation, and therapeutics discovery. The foundation also invests in early-stage cancer diagnostics and therapeutics companies. | Consultant / Advisor | - | - |
░░░ ░░░░░░░░░░ ░░ ░░░░░ ░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - | - |
Historique de carrière de Daniel K. Nomura
Formation de Daniel K. Nomura
University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Belgique | 2 |
Opérationnelle
Consultant / Advisor | 8 |
Founder | 2 |
Private Equity Investor | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 10 |
---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Finance |
AH Capital Management LLC
AH Capital Management LLC Investment ManagersFinance AH Capital Management LLC (AH Capital Management) is a venture capital firm founded in 2009 by Marc Lowell Andreessen and Ben A. Horowitz. The firm is headquartered in Menlo Park, California. | Finance |
Mark Foundation
Mark Foundation Miscellaneous Commercial ServicesCommercial Services The Mark Foundation for Cancer Research is a charitable organization that partners with scientists worldwide to accelerate research for the prevention, diagnosis, and treatment of cancer. The Mark Foundation is based in New York, NY and was founded by Alexander Mark Knaster. The foundation has awarded over $200 million in grants to more than 100 academic institutions across 13 countries since 2017. The non-profit company's research programs focus on early career support, team science collaboration, new technology innovation, and therapeutics discovery. The foundation also invests in early-stage cancer diagnostics and therapeutics companies. | Commercial Services |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Health Technology |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky. | Health Technology |
Apertor Pharmaceuticals, Inc.
Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Alameda, CA. | Health Technology |
Photys Therapeutics, Inc.
Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Health Technology |
Droia Ventures | |
Vicinitas Therapeutics
Vicinitas Therapeutics BiotechnologyHealth Technology Vicinitas Therapeutics is located in the US. Vicinitas Therapeutics is an American US-based biotechnology company that specializes in developing next-generation disease therapies using targeted protein stabilizers called Deubiquituinase Targeting Chimeras (DUBtacs). The company's mission is to solve critical problems in human health by developing disease therapies against an entire class of previously inaccessible disease-causing proteins. | Health Technology |
- Bourse
- Insiders
- Daniel K. Nomura
- Expérience